Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
about
Non-surgical versus surgical treatment for oesophageal cancerSurgical versus non-surgical treatment for oesophageal cancerFeeding Challenges in Patients with Esophageal and Gastroesophageal CancersDefinitive, Preoperative, and Palliative Radiation Therapy of Esophageal CancerPerioperative and Palliative Chemotherapy for Esophageal CancerPredicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature ReviewUnderstanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and SurvivalSurgical indications and optimization of patients for resectable esophageal malignanciesRadiation therapy and esophageal cancerThe role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tractInvolved-field radiotherapy for esophageal squamous cell carcinoma: theory and practiceAdvances in Radiotherapy Management of Esophageal CancerNeoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatmentCurrent Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis.A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.Tumor heterogeneity: causes and consequencesHigh dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients.Current management of esophageal cancerEsophageal cancer: staging system and guidelines for staging and treatment.Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomesGenetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.Current strategies in chemoradiation for esophageal cancer.Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinomaFeasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancerHigh-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study.Esophageal cancer management controversies: Radiation oncology point of viewBiweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation studyTreatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centreOesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographicsOutcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma.Comparison Between Concurrent Chemoradiation Followed by Surgery vs. Surgery for Locally Advanced Cancer of EsophagusA nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcomeEndoscopic spray cryotherapy for esophageal cancer: safety and efficacy
P2860
Q24186005-4236447D-60C8-48AF-AF40-30A334FEC796Q24186841-7A2F1080-8181-446E-A439-8A7D6B7D1C1CQ26741107-4591EC11-C9D0-4C55-A2F7-9B0F8F7D0905Q26753864-D779C514-D42E-465C-A957-E4EBADE24FF3Q26753865-DBAEFBAC-1886-4E00-849C-DD7B2874BCEAQ26777898-862B2789-F89E-4F7F-AC13-8D014439FA42Q26798220-DEE085C6-FB28-40E7-B4A1-8837A78FC2F8Q26861000-6AA3FEC9-B8AC-41E3-9785-E1C9B1BB0546Q27026922-D29BDFB3-118A-46A4-948E-0DA786D63AACQ27687612-99665017-3BDB-4652-B7AA-80BB4D16A541Q28073933-A057F1A0-E416-4555-88ED-F3FED85F5601Q28078750-57E1104A-D04E-4E0A-97F5-BA47EFCFEF70Q28086781-9477D823-776F-42B5-983E-C44B2A364344Q30244382-7AC1CCF2-1BEB-4DE2-9801-DE9A6C787840Q30252101-62FC46FF-2F96-4EFE-B42A-E56D05519DB5Q30393722-4D4B3778-89AB-4F8E-8232-C27D80BAF839Q33439909-857F345F-5A95-4582-ACC7-7D4D06BA39E9Q33624298-161200BE-960F-4BCB-8933-7F1C1024E6A9Q33633596-0E2EF791-4DE2-4074-B411-20DF9EB5B52AQ33633972-C791F44E-2C12-468D-8743-8B0B1EA7C7B6Q33658207-2D25E668-7C22-41E6-B4D3-00A3674AC6F0Q33680811-C620F008-5F67-45BC-8FBF-512FECEC63A2Q33702692-434C3DA0-43C6-418B-86F9-06EA343E82EDQ33779432-2025E866-53CF-4469-A32C-7896D38467F2Q33798433-6FAD0282-48BD-4F6D-A315-8315C4FD6EBBQ33820782-DEC8942B-5523-4F4D-8CBB-7E5519879370Q33891544-C258F59C-374C-4595-9E25-15A4F2AD1D6DQ33918140-51C6FDEE-E02A-4035-97B5-A93346A7DD89Q33933542-5B5D765C-7E72-49BB-95C6-557BAB3E87D0Q34049113-20A44A66-D8E4-41A7-8FDC-CD2453092D26Q34204650-F86B2090-A88D-474F-9321-B49875CB7A12Q34231941-A03C5EAE-DA63-4701-87DD-FDE2D6E0D888Q34374229-ECD4A647-AFBB-4498-971F-FE7A54AF0A82Q34382399-2D897FFB-2734-4A31-BEF8-60CECD1B4745Q34488764-56AE947B-3916-4EF1-BFB8-0FE82F14E117Q34753345-2D704AB0-5E44-4F49-ADD2-CA69438AD268Q34796876-CD25DF40-6263-49BE-9B97-C916A776222CQ34961992-9E92B390-6E78-4A35-BFC7-DE8399D7276EQ34980099-18053651-353A-4088-9F63-7C12F3A1FF1AQ35129311-21870B03-496F-4278-BDC9-3D686F4A103B
P2860
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.
@en
Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.
@nl
type
label
Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.
@en
Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.
@nl
prefLabel
Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.
@en
Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.
@nl
P2093
P356
P1476
Chemoradiation followed by sur ...... r of the esophagus: FFCD 9102.
@en
P2093
Bernard Paillot
Bernard Roullet
Chantal Milan
Christine Binquet
Christophe Mariette
Denis Pezet
Franck Bonnetain
Jean-François Seitz
Jean-Philippe Herr
Laurent Bedenne
P304
P356
10.1200/JCO.2005.04.7118
P407
P577
2007-04-01T00:00:00Z